Incidence and MortalityRate Trends
Lung cancer is the second most common cancerand the most common cause o cancer-relateddeath in both men and women in the UnitedStates. The overall mortality rate or lung andbronchus cancer rose steadily through the 1980sand peaked around 1990. Although incidenceand mortality rates or men have dropped in thelast decade, a similar trend has not occurredin women. Mortality rates are highest amongArican American males, ollowed by whitemales.It is estimated that approximately $9.6 billion
1
isspent in the United States each year on treatmento lung cancer.
Source or incidence and mortality data: Surveillance,Epidemiology, and End Results (SEER) Program and theNational Center or Health Statistics. Additional statisticsand charts are available athttp://seer.cancer.gov/ .
Medical Care
2002 Aug; 40 (8 Suppl): IV-104–17.
Trends in NCI Funding forLung Cancer Research
The National Cancer Institute’s (NCI’s) investment
2
in lung cancer research has increased rom$237.5 million in scal year 2002 to $242.9million in scal year 2006.
2
The estimated NCI investment is based on undingassociated with a broad range o peer-reviewed scienticactivities. For additional inormation on research planningand budgeting at NIH, seehttp://www.nih.gov/about/ .
U.S. Lung and Bronchus Cancer Incidence
d e n c e p e r 1 0 0 , 0 0 0 I n c i
198419881992199620002004160140120100806040200
U.S. Lung and Bronchus Cancer Mortality
M o r t a l i t y p e r 1 0 0 , 0 0 0
1984 19881992199620002004
160140120100806040200
NCI Lung Cancer Research Investment
White MalesOverall RateAfrican American MalesWhite FemalesAfrican American Females
$273.5M$276.5M$266.1M$242.9M$237.5M
Fiscal Year
s M i l l i o n s o f D o l l a r s B i l l i o n s o f D o l l a r
02002200420032005200650100150200300012345
i$4.2B$4.6B$4.7B$4.7B$4.8B
Lung Cancer Funding Total NCI Budget
250
Leave a Comment